VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AGIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AGIOAgios Pharmaceuticals, Inc.
$38.04$2.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAGIOQuarterly Financials

Agios Pharmaceuticals, Inc. (AGIO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Agios Pharmaceuticals, Inc. (AGIO) quarterly income statement — complete revenue, gross profit & net income history

AGIO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue20.75M19.97M12.88M12.46M8.73M10.73M8.96M8.62M8.19M7.1M7.4M6.71M5.61M4.31M3.52M5.58M832K000
Revenue Growth %137.75%86.09%43.69%44.57%6.56%51.06%21.15%28.35%46%64.8%110.44%20.24%574.16%-----100%-100%-100%
Cost of Goods Sold2.68M3.15M3.05M2.96M2.36M1.26M783K3.09M1.98M1.99M633K5.57M4.95M4.79M5.01M5.21M5.25M4.61M4.58M4.69M
COGS % of Revenue12.93%15.75%23.7%23.77%27.08%11.74%8.73%35.84%24.12%28%8.56%82.99%88.29%111.14%142.52%93.32%631.37%---
Gross Profit18.06M16.82M9.83M9.49M6.36M9.47M8.18M5.53M6.21M5.11M6.77M1.14M657K-480K-1.5M373K-4.42M-4.61M-4.58M-4.69M
Gross Margin %87.07%84.25%76.3%76.23%72.92%88.26%91.27%64.16%75.88%72%91.44%17.01%11.71%-11.14%-42.52%6.68%-531.37%---
Gross Profit Growth %183.89%77.63%20.12%71.77%2.4%85.18%20.91%383.98%845.81%1165.42%552.58%206.17%114.86%89.59%67.34%107.95%9.7%-110.7%-113.44%-112.8%
Operating Expenses128.09M138.4M126.7M136.55M112.99M134.51M110.99M111.34M98.29M111.39M107.66M94.84M91.27M98.69M89.59M98.01M96.72M100.22M86.57M86.53M
OpEx % of Revenue617.42%693.14%983.66%1096.35%1294.89%1253.56%1238.2%1292.44%1200.22%1568.22%1455.1%1413.02%1627.21%2289.84%2548.21%1755.88%11625.48%---
Selling, General & Admin48.3M51.61M41.27M45.87M41.53M51.7M38.54M35.54M31.01M35.3M25.82M27.75M25.76M30.21M26.61M25.78M29.08M29.12M24.78M26.87M
SG&A % of Revenue232.84%258.48%320.45%368.28%475.9%481.8%429.91%412.49%378.73%497.04%348.99%413.5%459.24%700.88%756.83%461.86%3495.07%---
Research & Development79.78M86.79M85.42M90.68M71.47M82.81M72.45M75.81M67.27M76.09M81.84M67.09M65.51M68.48M62.98M72.23M67.64M71.1M61.79M59.66M
R&D % of Revenue384.58%434.67%663.21%728.07%818.99%771.76%808.29%879.95%821.49%1071.18%1106.11%999.52%1167.96%1588.96%1791.38%1294.02%8130.41%---
Other Operating Expenses00000000000000000000
Operating Income-110.03M-121.58M-116.87M-127.06M-106.63M-125.04M-102.81M-105.82M-92.07M-106.28M-100.9M-93.7M-90.61M-99.17M-91.09M-97.64M-101.14M-104.83M-91.15M-91.22M
Operating Margin %-530.34%-608.89%-907.37%-1020.12%-1221.97%-1165.3%-1146.93%-1228.29%-1124.34%-1496.23%-1363.66%-1396.01%-1615.49%-2300.97%-2590.73%-1749.19%-12156.85%---
Operating Income Growth %-3.18%2.77%-13.67%-20.07%-15.81%-17.65%-1.9%-12.93%-1.61%-7.16%-10.77%4.04%10.41%5.39%0.07%-7.04%-10.88%-13.41%-0.91%-1.14%
EBITDA-108.66M-120.31M-115.5M-125.8M-105.35M-123.67M-101.47M-104.22M-90.72M-104.87M-99.27M-89.24M-86.22M-94.8M-86.6M-92.87M-96.23M-100.22M-86.57M-86.53M
EBITDA Margin %-523.77%-602.55%-896.7%-1010.01%-1207.32%-1152.56%-1131.93%-1209.8%-1107.88%-1476.47%-1341.72%-1329.53%-1537.08%-2199.42%-2462.91%-1663.67%-11566.23%---
EBITDA Growth %-3.14%2.72%-13.83%-20.7%-16.12%-17.92%-2.21%-16.79%-5.23%-10.63%-14.64%3.91%10.41%5.41%-0.03%-7.32%-11.48%-11.65%1.63%1.43%
D&A (Non-Cash Add-back)1.36M1.27M1.37M1.26M1.28M1.37M1.34M1.59M1.35M1.4M1.62M4.46M4.4M4.38M4.49M4.77M4.91M4.61M4.58M4.69M
EBIT-110.03M-121.58M-116.87M-127.06M-106.63M-125.04M-102.81M-105.82M-92.07M-106.28M-100.9M-83.81M-81.02M36.53M-81.75M-91.81M-94.77M-98.58M-84.26M-82.7M
Net Interest Income10.79M12.41M13.37M14.51M16.09M18.02M13.06M8.12M8.89M8.62M8.38M8.25M8.09M6.49M3.82M1.79M694K332K256K-92K
Interest Income10.79M12.41M13.37M14.51M16.09M18.02M13.06M8.12M8.89M8.62M8.38M8.25M8.09M6.49M3.82M1.79M694K332K256K0
Interest Expense000000000000000000092K
Other Income/Expense10.91M12.52M13.44M15.04M17.34M19.64M1.1B9.7M10.52M10.34M9.57M9.89M9.6M135.7M9.34M5.83M6.37M6.24M6.89M8.43M
Pretax Income-99.11M-109.06M-103.43M-112.02M-89.29M-105.4M1B-96.12M-81.55M-95.94M-91.32M-83.81M-81.02M36.53M-81.75M-91.81M-94.77M-98.58M-84.26M-82.79M
Pretax Margin %-477.74%-546.18%-803.05%-899.4%-1023.25%-982.28%11167.28%-1115.71%-995.84%-1350.7%-1234.27%-1248.6%-1444.43%847.47%-2325%-1644.68%-11391.11%---
Income Tax0-1.02M000-8.88M53.12M0000000000000
Effective Tax Rate %0%0.93%0%0%0%8.42%5.31%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-99.11M-108.04M-103.43M-112.02M-89.29M-96.52M947.91M-96.12M-81.55M-95.94M-91.32M-83.81M-81.02M36.53M-81.75M-91.81M-94.77M-94.63M-88.15M-83.42M
Net Margin %-477.74%-541.09%-803.05%-899.4%-1023.25%-899.56%10574.69%-1115.71%-995.84%-1350.7%-1234.27%-1248.6%-1444.43%847.47%-2325%-1644.68%-11391.11%---
Net Income Growth %-11%-11.93%-110.91%-16.54%-9.49%-0.61%1137.97%-14.69%-0.66%-362.66%-11.72%8.71%14.51%138.6%7.26%-10.06%19.84%3.1%10.94%7.8%
Net Income (Continuing)-99.11M-108.04M-103.43M-112.02M-89.29M-96.52M947.91M-96.12M-81.55M-95.94M-91.32M-83.81M-81.02M36.53M-81.75M-91.81M-94.77M-98.58M-84.26M-82.79M
Discontinued Operations000000000000000001000K-1000K-627K
Minority Interest00000000000000000000
EPS (Diluted)-1.69-1.85-1.78-1.93-1.55-1.6916.22-1.69-1.45-1.72-1.64-1.51-1.293.14-1.32-1.68-1.62-1.74-1.56-1.41
EPS Growth %-9.03%-9.47%-110.97%-14.2%-6.9%1.74%1089.02%-11.92%-12.4%-154.78%-24.24%10.12%20.37%280.46%15.38%-19.15%-106.01%-23.4%-9.09%-7.63%
EPS (Basic)-1.69-1.85-1.78-1.93-1.55-1.6916.65-1.69-1.45-1.72-1.64-1.51-1.303.14-1.32-1.68-1.62-1.74-1.56-1.41
Diluted Shares Outstanding58.78M58.33M58.14M57.93M57.46M57.16M58.43M56.8M56.38M55.9M55.8M55.6M55.27M54.79M54.84M54.8M54.56M54.34M57.05M61.07M
Basic Shares Outstanding58.78M58.33M58.14M57.93M57.46M57.16M56.94M56.8M56.38M55.9M55.8M55.5M55.11M54.79M54.84M54.8M54.47M54.34M57.05M61.07M
Dividend Payout Ratio--------------------